Heart
Transport Systems Market, by Disease Indication (Heart failure,
Cardiomyopathy, Congenital Heart Defect, Coronary Heart Disease and Others), by
End User (Hospitals, Cardiac Centers, and Research Centers), and by Geography
(North America, Asia Pacific, Europe, Latin America, Middle East, and Africa) -
Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026
Heart transport systems are
devices used for maintenance and nourishment of heart while it is being
transported from harvest in preparation for transplantation. Heart
transportation is a highly critical process as the heart can only be preserved
for around 4 hours in an ice box. Advanced transport systems such as LifeCradle
product developed by Organ Transport Systems can preserve heart for 12 hours.
The Global Heart Transport System
– Market Dynamics
Increasing prevalence of
cardiovascular diseases that often require heart transplant surgeries and
government initiatives in funding for research and development in heart
transplant surgeries are major factors driving growth of the global heart
transport systems market. According to The International Society for Heart and
Lung Transplantation, in 2014, around 586 heart transplant surgeries were
performed worldwide.
* The sample copy includes:
Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report
Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2405
Increasing stress among the
populace along with sedentary work, high fat intake, and congenital defects in
heart also increase demand for heart transplant. This in turn boosts growth of
the global heart transport systems market.
The Global Heart Transport
Systems Market – Regional Insights
North America accounted for the
largest share in the global heart transport systems market in 2017, owing to
increasing number of people diagnosed with coronary artery disease, heart
failure, and cardiomyopathy. According to the U.S. Pediatric Cardiomyopathy
Registry, the annual incidence of cardiomyopathy in the U.S. was around 1.13
per 10, 00,000 children younger than 18 years of age. Europe accounted for the
second largest share in the market in terms of revenue, owing to increasing
research and development activities in heart transport systems. . Market in
Asia Pacific is expected to witness the fastest growth, owing to increasing
geriatric population in the region increases prevalence of cardiovascular
disease. For instance, according to a report published by Asia Pacific Journal,
in 2018, 7 out of 10 deaths are expected to cause due to cardiovascular
diseases by 2020.
Browse Research
Report: https://www.coherentmarketinsights.com/ongoing-insight/heart-transport-systems-market-2405
The Global Heart Transport System
– Competitive Landscape
Major players operating in the
global heart transport systems market include, Paragonix Technologies, Inc.,
Organ Transport Systems, Pulse Heart Transportation System, and others. Key
players in the market are focused on launching new heart transport systems in
order to enhance their market share. For instance, in December 2018, Paragonix
Technologies received approval from the U.S. Food and Drug Administration (FDA)
for its Paragonix Sherp, a cardiac transport system.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2405
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment